Cargando…

Description of the first two cases of Pompe disease in Bulgaria

Detalles Bibliográficos
Autores principales:	Tournev, I, Chamova, T, Sinigerska, I, Guergueltcheva, V, Gospodinova, M, Ganova, P, Stoilov, R, Todorova, A, Todorov, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666988/ http://dx.doi.org/10.1186/1471-2474-14-S2-P21

Ejemplares similares

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria
por: Sarafov, Stayko, et al.
Publicado: (2015)

Screening for hereditary transthyretin amyloidosis in Bulgaria
por: Nakov, Radislav, et al.
Publicado: (2021)

Cardiomyopathy and peripheral polyneuropathy severity in patients with Glu89Gln mutation at the time of diagnosis
por: Gospodinova, Mariana, et al.
Publicado: (2015)

Cardiac involvement and clinical follow up of patients with hereditary transthyretin related amyloidosis associated with Glu89Gln mutation
por: Gospodinova, Mariana, et al.
Publicado: (2015)

Glu89Gln transthyretin-related amyloidosis in Italy and Bulgaria: does geographic area influence phenotype beyond the shared mutation?
por: Gagliardi, Christian, et al.
Publicado: (2015)

Association Between Loss of Dp140 and Cognitive Impairment in Duchenne and Becker Dystrophies
por: Chamova, T, et al.
Publicado: ( 201)

Seven Years of Selective Genetic Screening Program and Follow-Up of Asymptomatic Carriers With Hereditary Transthyretin Amyloidosis in Bulgaria
por: Chamova, Teodora, et al.
Publicado: (2022)

Dietary habits of pregnant women in Bulgaria
por: Chamova, R, et al.
Publicado: (2022)

Rodents as reservoirs of human pathogens in Bulgaria
por: Christova, I, et al.
Publicado: (2014)

HIV epidemic in Bulgaria
por: Shamas, Simon
Publicado: (2012)

Case Report: Transthyretin Glu54Leu—a rare mutation with predominant cardiac phenotype
por: Gospodinova, Mariana, et al.
Publicado: (2023)

Muskoskeletal manifestations of mild form of mucopolysaccharidosis iva - a clinical case
por: Ganeva, Margarita, et al.
Publicado: (2014)

Spectrum of Pompe disease in childhood – The Toronto experience
por: Raiman, J, et al.
Publicado: (2013)

The Pompe Registry: tracking Pompe disease symptoms in a broad patient population
por: Byrne, B, et al.
Publicado: (2008)

Pompe disease: the role of MRI
por: Fernández, C Pérez, et al.
Publicado: (2013)

Cytokines in treated and untreated Pompe patients
por: Karabul, N, et al.
Publicado: (2013)

Attitudes towards mandatory vaccinations during the COVID-19 pandemic in Bulgaria: Stanislava Hadzhieva
por: Hadzhieva, S, et al.
Publicado: (2022)

Pompe practice survey of Canadian (Ontario) rheumatologists
por: Thorne, Carter, et al.
Publicado: (2013)

Pompe disease- experience from South India
por: Lingappa, Lokesh, et al.
Publicado: (2013)

Satisfaction of inpatients with acute coronary syndrome in Bulgaria
por: Ganova-Iolovska, Milka, et al.
Publicado: (2008)

Fear of infection or fear of protection – driving factors of COVID-19 vaccine uptake in Bulgaria: Stanislava Hadzhieva
por: Rohova, M, et al.
Publicado: (2022)

Enzyme replacement therapy and fatigue in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)

Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
por: van Gelder, C, et al.
Publicado: (2013)

Tuberculosos pandemic and dissemination of drug resistant strains: a challenge for Bulgaria
por: Valcheva, Violeta, et al.
Publicado: (2011)

Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment
por: Kazakov, Rossen M, et al.
Publicado: (2015)

Impact of enzyme replacement therapy on survival in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)

Walking delay as leading symptom in late-onset Pompe disease
por: Gökce, S, et al.
Publicado: (2013)

Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations
por: Nakov, Radislav, et al.
Publicado: (2020)

Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
por: Ebbink, BJ, et al.
Publicado: (2013)

Development of a disease severity scoring system for patients with Pompe disease
por: Giannini, E, et al.
Publicado: (2008)

Effects of exercise training in 23 adults with Pompe disease receiving enzyme therapy
por: van den Berg, Linda, et al.
Publicado: (2013)

Novel variant c.92T > G (p.Val31Gly) in the PFN1 gene (ALS18) responsible for a specific phenotype in a large Bulgarian amyotrophic lateral sclerosis pedigree
por: Angelov, Teodor, et al.
Publicado: (2023)

Navigating the ALS Genetic Labyrinth: The Role of MAPT Haplotypes
por: Tourtourikov, Ivan, et al.
Publicado: (2023)

A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
por: van Gelder, C, et al.
Publicado: (2013)

Quality of care of patients with acute myocardial infarction in Bulgaria: a cross-sectional study
por: Ganova-Iolovska, Milka, et al.
Publicado: (2009)

Feasibility of DBS screening to identify adult patients with Pompe disease in a neuromuscular clinic population
por: Genge, Angela
Publicado: (2013)

Left sleeve pneumonectomy performed through a sternotomy incision with cardiopulmonary bypass for bronchogenic carcinoma: report of two cases
por: Minchev, Ts, et al.
Publicado: (2013)

Restrictions on access to medical care for the uninsured in Bulgaria
por: Kostadinov, S, et al.
Publicado: (2023)

Immunological effect of ten-year c-ART in treatment-naive and pre-treated HIV-1 patients in Bulgaria
por: Elenkov, Ivaylo, et al.
Publicado: (2012)

Pregnancy in Pompe disease
por: Plöckinger, Ursula
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kjk8i0p5en5i9d0o6h1l748dm2